4.7 Article

A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medical Laboratory Technology

Review of the Clinical Presentation, Pathology, Diagnosis, and Treatment of Leishmaniasis

Blaine A. Mathison et al.

Summary: Leishmaniasis is a vector-borne infection caused by protozoans, commonly found in tropical and subtropical regions, and can be particularly burdensome in areas with limited resources. Accurate diagnosis is crucial for proper clinical management, but it can be complicated due to the diversity of species and diagnostic methods. This mini-review provides an overview of Leishmania epidemiology, biology, pathogenesis, clinical presentations, and treatments, with a focus on the nuances involved in diagnosis.

LABORATORY MEDICINE (2023)

Article Immunology

Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses

Maritsa Margaroni et al.

Summary: In this study, a multi-epitope chimeric protein called LeishChim was designed using a reverse vaccinology approach. It was found to be stable, non-allergenic, and immunogenic, with the ability to bind strongly to MHCI and MHCII molecules. Preclinical evaluation in mice demonstrated its potential as a vaccine candidate.

VACCINES (2023)

Article Veterinary Sciences

The Leishmaniasis

Gad Baneth et al.

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2022)

Review Microbiology

Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs

Malcolm S. Duthie et al.

Summary: Leishmania parasites cause various diseases and only a few vaccine candidates have advanced to clinical trials. RNA technology shows potential benefits in addressing the challenges of Leishmania vaccine development. Strategies, including controlled human infection models and initial use in a therapeutic setting, can efficiently evaluate the efficacy of Leishmania vaccines.

PATHOGENS (2022)

Article Pharmacology & Pharmacy

Advancement in leishmaniasis diagnosis and therapeutics: An update

Diksha Kumari et al.

Summary: Leishmaniasis is considered a neglected tropical disease by WHO and ranks second to malaria in terms of lethality. Accurate diagnosis is crucial due to involvement of multiple Leishmania species. New treatment methods for leishmaniasis include host-directed therapies, drug repurposing, nanotechnology, and combinational therapy.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Biotechnology & Applied Microbiology

Emerging concepts in the science of vaccine adjuvants

Bali Pulendran et al.

Summary: Adjuvants are vaccine components that enhance the immune response. Recent advances in understanding the molecular mechanisms and systems vaccinology have revitalized the science and development of novel adjuvants for use in vaccines against COVID-19 and future pandemics.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Infectious Diseases

A Review of Leishmaniasis: Current Knowledge and Future Directions

Sarah Mann et al.

Summary: This review summarizes the current knowledge of cutaneous, mucosal, and visceral leishmaniasis in terms of epidemiology, clinical manifestations, diagnosis, and treatment. The article also discusses newer tests, vaccine candidates, and updated treatment recommendations for leishmaniasis. Understanding the prominent clinical manifestations and major parasite species can help guide recommendations for diagnosis and treatment of this complex disease.

CURRENT TROPICAL MEDICINE REPORTS (2021)

Review Public, Environmental & Occupational Health

Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy

Rita Velez et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)

Article Immunology

Strength and medium-term impact of HisAK70 immunization in dogs: Vaccine safety and biomarkers of effectiveness for ex vivo Leishmania infantum infection

Abel Martinez-Rodrigo et al.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2019)

Review Immunology

Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments

Shubhranshu Zutshi et al.

VACCINES (2019)

Review Immunology

Structure and function of the immune system in the spleen

Steven M. Lewis et al.

SCIENCE IMMUNOLOGY (2019)

Review Parasitology

Leishmaniasis and various immunotherapeutic approaches

Y. Taslimi et al.

PARASITOLOGY (2018)

Review Immunology

Vaccine candidates against leishmania under current research

Salvador Iborra et al.

EXPERT REVIEW OF VACCINES (2018)

Article Multidisciplinary Sciences

Canine Leishmaniasis Progression is Associated with Vitamin D Deficiency

A. Rodriguez-Cortes et al.

SCIENTIFIC REPORTS (2017)

Review Immunology

The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis

Suenia da C. Goncalves-de-Albuquerque et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Immunology

Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells

Gustavo Dominguez-Bernal et al.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2017)

Article Pediatrics

Visceral leishmaniasis: a forgotten epidemic

Eduard E. Zijlstra

ARCHIVES OF DISEASE IN CHILDHOOD (2016)

Article Cell Biology

Memory T cells in cutaneous leishmaniasis

Nelson D. Glennie et al.

CELLULAR IMMUNOLOGY (2016)

Review Parasitology

Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis

Mariana Costa Duarte et al.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2016)

Review Infectious Diseases

A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies

Mohammad Akhoundi et al.

PLOS NEGLECTED TROPICAL DISEASES (2016)

Review Immunology

Cutaneous leishmaniasis: immune responses in protection and pathogenesis

Phillip Scott et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Immunology

Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection

Nelson D. Glennie et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Parasitology

HisAK70: progress towards a vaccine against different forms of leishmaniosis

Gustavo Dominguez-Bernal et al.

PARASITES & VECTORS (2015)

Review Immunology

Challenges and responses in human vaccine development

Stefan H. E. Kaufmann et al.

CURRENT OPINION IN IMMUNOLOGY (2014)

Article Public, Environmental & Occupational Health

Three Leishmania/L. species - L-infantum, L-major, L-tropica - as causative agents of mucosal leishmaniasis in Iran

Sadegh Shirian et al.

PATHOGENS AND GLOBAL HEALTH (2013)

Article Infectious Diseases

UCP2 Deficiency Helps to Restrict the Pathogenesis of Experimental Cutaneous and Visceral Leishmaniosis in Mice

Javier Carrion et al.

PLOS NEGLECTED TROPICAL DISEASES (2013)

Article Multidisciplinary Sciences

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Jorge Alvar et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

The Increase in Mannose Receptor Recycling Favors Arginase Induction and Trypanosoma Cruzi Survival in Macrophages

Vanina V. Garrido et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)

Review Parasitology

LeishVet guidelines for the practical management of canine leishmaniosis

Laia Solano-Gallego et al.

PARASITES & VECTORS (2011)

Article Immunology

L-arginine metabolism and its impact on host immunity against Leishmania infection

Nanchaya Wanasen et al.

IMMUNOLOGIC RESEARCH (2008)